Portage Biotech Files 6-K, Incorporates into S-8

Ticker: ATON · Form: 6-K · Filed: Feb 12, 2025 · CIK: 1095435

Sentiment: neutral

Topics: reporting, sec-filing, registration-statement

TL;DR

Portage Biotech filed a 6-K, linking it to their S-8 registration. Standard reporting.

AI Summary

Portage Biotech Inc. filed a Form 6-K on February 12, 2025, to report information for the month of February 2025. The filing is incorporated by reference into their Form S-8 registration statement (File No. 333-275842). The company is located in Tortola, British Virgin Islands.

Why It Matters

This filing indicates ongoing reporting requirements and potential future stock issuances or grants related to employee compensation or incentive plans.

Risk Assessment

Risk Level: low — This is a routine filing for a public company and does not contain new financial or operational information that would immediately impact risk.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing?

The primary purpose is to report information for the month of February 2025 and to be incorporated by reference into Portage Biotech Inc.'s registration statement on Form S-8 (File No. 333-275842).

When was this Form 6-K filed?

This Form 6-K was filed on February 12, 2025.

What is the company's principal executive office address?

The company's principal executive office is located at Clarence Thomas Building, P.O. Box 4649, Road Town, Tortola, British Virgin Islands, VG1110.

Does Portage Biotech Inc. file annual reports under Form 20-F or 40-F?

Yes, Portage Biotech Inc. indicates it files annual reports under cover of Form 20-F.

What is the SIC code for Portage Biotech Inc.?

The Standard Industrial Classification (SIC) code for Portage Biotech Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 302 words · 1 min read · ~1 pages · Grade level 11.7 · Accepted 2025-02-12 16:20:48

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Portage Biotech Inc. (Registrant) Date: February 12, 2025 /s/ Andrea Park Andrea Park Chief Financial Officer

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing